Skip to main content
    O

    OmniAb Inc. (OABI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.73
    +0.18 (+3.96%)

    Market Cap: $661.53M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    60%(9/15)
    Avg Surprise
    +19.84%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.13
    Range$-0.14 - $-0.12
    4 analysts
    EPS Revisions
    1
    0
    7d
    1
    3
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.12-10.6%
    60d ago$-0.13+2.5%
    30d ago$-0.130.0%
    7d ago$-0.130.0%
    Current$-0.13
    Revenue Consensus
    $3M
    Range$3M - $4M
    7 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.01
    Range$-0.04 - $0.01
    5 analysts
    Revenue Consensus
    $21M
    Range$19M - $23M
    7 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.01---
    Sep 26EST
    		-$-0.13---
    Jun 26
    Reported Aug 6
    		$-0.05N/A+54.55%Beat+66.7%
    Mar 26
    Reported May 7
    		$-0.06$-0.10+40.00%Beat+64.7%
    Dec 25
    Reported Mar 4
    		$-0.11$-0.09-25.71%Miss+8.3%
    Sep 25
    Reported Nov 4
    		$-0.14$-0.14+0.00%Beat+12.5%
    Jun 25
    Reported Aug 6
    		$-0.15$-0.15+0.00%Beat-15.4%
    Mar 25
    Reported May 8
    		$-0.17$-0.17+0.00%Beat+10.5%
    Dec 24
    Reported Mar 18
    		$-0.12$-0.10-24.10%Miss+14.3%
    Sep 24
    Reported Nov 12
    		$-0.16$-0.14-14.29%Miss+0.0%
    Jun 24
    Reported Aug 8
    		$-0.13$-0.17+23.53%Beat+13.3%
    Mar 24
    Reported May 9
    		$-0.19$-0.16-18.75%Miss-216.7%
    Dec 23
    Reported Mar 20
    		$-0.14$-0.15+6.67%Beat-300.0%
    Sep 23
    Reported Nov 9
    		$-0.16$-0.13-23.08%Miss-77.8%
    Jun 23
    Reported Aug 10
    		$-0.15$-0.12-25.00%Miss-150.0%
    Mar 23
    Reported May 11
    		$-0.06N/A+53.85%Beat+62.5%
    Dec 22
    Reported Mar 30
    		$0.07$0.02+250.00%Beat+800.0%
    Sep 22
    Reported Nov 10
    		$-0.09$0.00N/AMiss-800.0%
    Jun 22
    Reported Aug 12
    		$-0.06N/AN/ABeat-
    Mar 22
    Reported May 20
    		$-0.16N/AN/ABeat-
    Dec 21
    Reported Mar 25
    		$-0.01N/AN/ABeat-
    Sep 21
    Reported Nov 10
    		$-0.01N/AN/ABeat-
    Jun 21
    Reported Sep 23
    		$0.00$0.00N/ABeat-
    Mar 21
    Reported Jun 29
    		$0.00$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-13.14EV/EBITDAN/A
    Price/FCF-33.58xFCF Yield-2.98%
    Profitability
    Profit Margin-115.10%Operating Margin-49.50%
    ROE-17.00%ROIC-16.95%
    Financial Health
    Debt/Equity0.06xInterest CoverageN/A
    Current Ratio4.80xQuick Ratio4.80x
    Trading Statistics
    Beta1.37Avg Volume1.26M
    52-Week High$5.4352-Week Low$1.30

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$4.69
    SMA 20$4.72
    SMA 50$4.35
    SMA 200$2.54
    EMA 10$4.69
    EMA 20$4.64
    EMA 50$4.21
    EMA 200$2.92

    MACD

    Line: 0.11Signal: 0.16Hist: -0.05

    ADX

    ADX: 30.8+DI: 18.1-DI: 15.8

    Aroon & PSAR

    Aroon Up64.0
    Aroon Down4.0
    PSAR$4.97

    Bollinger Bands

    Upper Band$5.06
    Lower Band$4.39
    %B Position1428%(Upper)
    Band Width0.51

    RSI (14-Day)

    Neutral
    54.4

    Momentum Oscillators

    Stoch %K50.9
    Stoch %D54.9
    Williams %R-41.1
    ROC (10d)-5.2%
    Momentum-0.26
    CCI (20d)-23.4
    MFI (14d)51.7

    Volatility Measures

    ATR (14d)$0.31(6.6%)
    StdDev (20d)0.17
    Hist Vol64.6%(High)

    Volume Flow

    VWAP$4.67
    OBV55.8M
    AD Line-1.1M
    CMF (20d)0.180

    Volume Metrics

    Avg Vol (20d)1.3M
    Vol Ratio0.6x
    VWMA (20d)$4.72

    Pivot Points

    R3$5.04
    R2$4.94
    R1$4.74
    Pivot Point$4.64
    S1$4.44
    S2$4.34
    S3$4.14

    Advanced Oscillators

    TSI10.77
    Ultimate Osc58.8
    KST80.82

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$13.41M$14.43M$8.38M$2.24M$3.90M$4.15M$10.80M$4.17M$7.61M$3.80M$4.82M$5.48M
    Cost of Revenue$610,000$15,000$12,000$29,000$262,000$3,000$11.05M$0$0$0$4.93M$0
    Gross Profit$12.80M$14.41M$8.36M$2.21M$3.63M$4.15M$10.80M$4.17M$7.61M$3.80M$4.82M$5.48M
    Operating Expenses$19.44M$22.24M$24.13M$20.35M$19.85M$23.00M$26.68M$23.94M$23.92M$26.35M$26.03M$25.79M
    R&D$9.59M$9.64M$13.91M$10.38M$10.86M$12.60M$13.31M$13.32M$13.94M$14.55M$14.77M$13.87M
    SG&A$6.65M$6.62M$6.84M$6.78M$7.68M$7.92M$7.36M$7.08M$7.96M$8.34M$7.87M$8.51M
    Operating Income$-6,637,000$-7,829,000$-15,766,000$-18,140,000$-16,219,000$-18,844,000$-15,880,000$-19,764,000$-16,305,000$-22,553,000$-21,206,000$-20,315,000
    Interest Income$434,000$487,000$1.23M$462,000$436,000$537,000$655,000$691,000$785,000$975,000$1.18M$1.26M
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-6,212,000$-7,265,000$-14,546,000$-17,686,000$-15,756,000$-18,306,000$-15,223,000$-19,081,000$-15,529,000$-21,578,000$-20,028,000$-19,042,000
    Income Tax Expense$-353,000$442,000$-367,000$-1,161,000$119,000$-106,000$-2,155,000$-2,708,000$-1,898,000$-2,617,000$-5,975,000$-3,304,000
    Net Income$-5,859,000$-7,707,000$-14,179,000$-16,525,000$-15,875,000$-18,200,000$-13,068,000$-16,373,000$-13,631,000$-18,961,000$-14,053,000$-15,738,000
    EBITDA$-2,573,000$-737,000$-8,308,000$-13,665,000$-11,746,000$-14,339,000$-8,485,000$-15,131,000$-10,590,000$-18,226,000$-17,062,000$-16,291,000
    EBIT$-6,646,000$-7,752,000$-15,771,000$-18,148,000$-16,192,000$-18,843,000$-15,878,000$-19,772,000$-16,314,000$-22,553,000$-21,206,000$-20,307,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about OABI

    News

    OmniAb to Report Third Quarter 2026 Financial Results on October 30

    OmniAb, Inc. (NASDAQ: OABI) announced it will report its financial results for the third quarter and nine months ended September 30, 2026, before the U.S. financial markets open on Friday, October 30...

    Yahoo Finance•10/15/26•Neutral

    Press Release: OmniAb to Report Third Quarter 2026 Financial Results on October 30

    OmniAb announced it will report its third quarter 2026 financial results on October 30, 2026. The company will issue a press release after market close...

    Moomoo•10/15/26•Neutral

    OmniAb Q3FY26 Results: Earnings call set for October 30

    OmniAb, Inc. will report its financial results for Q3FY26 on October 30, 2026, before the U.S. financial markets open. The company will host a conference call on the same day at 8:00 a.m. Eastern time to discuss...

    scanx.trade•10/14/26•Neutral

    OmniAb Leads The Pack Of 3 Intriguing Penny Stocks

    This article identifies three intriguing penny stocks with strong financial health and long-term potential: OmniAb (OABI), Taboola.com (TBLA), and SES AI (SES). OmniAb, a biotechnology company...

    Simply Wall Street•10/14/26•Somewhat-Bullish

    StoneX raises OmniAb stock price target to $6 on new products

    StoneX has increased its price target for OmniAb Inc. (NASDAQ:OABI) shares to $6.00 from $4.00, reiterating a Buy rating. This adjustment follows OmniAb's Investor and Analyst Day...

    Investing.com•10/8/26•Bullish

    OABI Valuation and Fair Value

    P/E
    -13.1x
    P/FCF
    -33.6x
    P/B
    2.3x
    See GNG's fair value

    OABI Profitability: Margins, ROIC and FCF

    Gross margin
    98.3%
    Operating margin
    -49.5%
    Net margin
    -115.1%
    ROIC
    -16.9%
    ROE
    -17.0%
    FCF margin
    -47.2%
    FCF yield
    -3.0%

    OABI Competitors

    CompanyTicker
    Pharming Group NVPHAR
    Phreesia IncPHR
    4D Molecular Therapeutics IncFDMT
    Avalo Therapeutics IncAVTX
    Inventiva SaIVA
    Performant Healthcare, IncPHLT
    Design Therapeutics IncDSGN
    Pacific Biosciences of CaliforniaPACB

    Sector: Healthcare

    OABI Analyst Ratings

    Consensus
    Buy
    Analysts
    7
    Strong Buy
    0
    Buy
    7
    Hold
    0
    Sell
    0
    Strong Sell
    0

    OABI Bull Case vs Bear Case

    Bull case

    • OABI grew quarterly revenue 244.2% year over year.
    • 100.0% of OABI's analyst ratings are Buy or Strong Buy.

    Bear case

    • OABI has a -115.1% net profit margin.
    • OABI beat EPS estimates in 25.0% of its last 8 reported quarters.

    OABI Earnings: Beat Rate and Next Report

    Beat rate
    2 of 8 quarters (25.0%)
    Average surprise
    3.8%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.13
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 3 down

    Frequently Asked Questions About OABI

    Does OABI pay dividends?

    OmniAb Inc. (OABI) does not currently pay a regular dividend.

    What is OABI's market cap?

    OmniAb Inc. (OABI) has a market capitalization of $661.53M with a current stock price of $4.73.

    Related stocks

    Sector: Healthcare

    All stocks starting with O

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In